Literature DB >> 9541860

ACTBP2-nomenclature recommendations of GEDNAP.

H R Schneider1, S Rand, H Schmitter, G Weichhold.   

Abstract

A system of nomenclature is proposed for the complex STR system ACTBP2 (SE33) in order to facilitate data exchange between laboratories. The nomenclature conforms to the ISFH recommendations as far as it is possible for such complex systems. A blind trial was carried out between up to 20 laboratories to ascertain the reproducibility of the nomenclature under working conditions. The population studies carried out have established that there are minimal regional differences in the allele frequencies and that the system of nomenclature is robust.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9541860     DOI: 10.1007/s004140050124

Source DB:  PubMed          Journal:  Int J Legal Med        ISSN: 0937-9827            Impact factor:   2.686


  5 in total

1.  A very long ACTBP2 (SE33) allele.

Authors:  R Klein; G Braunschweiger; A Junge; P Wiegand
Journal:  Int J Legal Med       Date:  2003-05-29       Impact factor: 2.686

2.  The GEDNAP blind trial concept part II. Trends and developments.

Authors:  S Rand; M Schürenkamp; C Hohoff; B Brinkmann
Journal:  Int J Legal Med       Date:  2004-01-31       Impact factor: 2.686

3.  Development of the AmpFISTR SEfiler PCR amplification kit: a new multiplex containing the highly discriminating ACTBP2 (SE33) locus.

Authors:  Sulekha Rao Coticone; Nicola Oldroyd; Heidi Philips; Paul Foxall
Journal:  Int J Legal Med       Date:  2004-05-15       Impact factor: 2.686

4.  Sequence-based US population data for the SE33 locus.

Authors:  Lisa A Borsuk; Katherine B Gettings; Carolyn R Steffen; Kevin M Kiesler; Peter M Vallone
Journal:  Electrophoresis       Date:  2018-06-01       Impact factor: 3.535

5.  Haplotype-assisted characterization of germline mutations at short tandem repeat loci.

Authors:  Miriam Müller; Ulla Sibbing; Carsten Hohoff; Bernd Brinkmann
Journal:  Int J Legal Med       Date:  2009-11-11       Impact factor: 2.686

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.